BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18532922)

  • 1. Novel vesicular and particulate drug delivery systems for topical treatment of acne.
    Castro GA; Ferreira LA
    Expert Opin Drug Deliv; 2008 Jun; 5(6):665-79. PubMed ID: 18532922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in topical delivery systems in acne: new solutions to address concentration dependent irritation and dryness.
    Ceilley RI
    Skinmed; 2011; 9(1):15-21. PubMed ID: 21409958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel drug delivery systems: potential in improving topical delivery of antiacne agents.
    Date AA; Naik B; Nagarsenker MS
    Skin Pharmacol Physiol; 2006; 19(1):2-16. PubMed ID: 16247244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing acne therapy with unique vehicles.
    Kircik L; Friedman A
    J Drugs Dermatol; 2010 May; 9(5 Suppl ODAC Conf Pt 1):s53-7. PubMed ID: 20518361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical Vehicle Formulations in the Treatment of Acne.
    Hoffman LK; Bhatia N; Zeichner J; Kircik LH
    J Drugs Dermatol; 2018 Jun; 17(6):s6-s10. PubMed ID: 29879262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic studies with a new combination benzoyl peroxide/clindamycin topical gel in acne vulgaris.
    Ellis CN; Leyden J; Katz HI; Goldfarb MT; Hickman J; Jones TM; Tschen E
    Cutis; 2001 Feb; 67(2 Suppl):13-20. PubMed ID: 11236210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, multicenter, parallel group study to compare relative efficacies of the topical gels 3% erythromycin/5% benzoyl peroxide and 0.025% tretinoin/erythromycin 4% in the treatment of moderate acne vulgaris of the face.
    Gupta AK; Lynde CW; Kunynetz RA; Amin S; Choi K; Goldstein E
    J Cutan Med Surg; 2003; 7(1):31-7. PubMed ID: 12362264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the vehicle in combination acne therapy.
    Del Rosso JQ
    Cutis; 2005 Aug; 76(2 Suppl):15-8. PubMed ID: 16164152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnological Advances for Cutaneous Release of Tretinoin: An Approach to Minimize Side Effects and Improve Therapeutic Efficacy.
    Raminelli ACP; Romero V; Semreen MH; Leonardi GR
    Curr Med Chem; 2018; 25(31):3703-3718. PubMed ID: 29532749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cumulative irritancy comparison of topical retinoid and antimicrobial combination therapies.
    Dosik JS; Gilbert RD; Arsonnaud S
    Skinmed; 2006; 5(5):219-23. PubMed ID: 16957432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin delivery aspects of benzoyl peroxide-loaded solid lipid nanoparticles for acne treatment.
    Pokharkar VB; Mendiratta C; Kyadarkunte AY; Bhosale SH; Barhate GA
    Ther Deliv; 2014 Jun; 5(6):635-52. PubMed ID: 25090278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterisation and skin uptake.
    Stecová J; Mehnert W; Blaschke T; Kleuser B; Sivaramakrishnan R; Zouboulis CC; Seltmann H; Korting HC; Kramer KD; Schäfer-Korting M
    Pharm Res; 2007 May; 24(5):991-1000. PubMed ID: 17372681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of the efficacy of four topical medications individually or in combination to treat grade I acne vulgaris.
    Biswas S; Mondal KK; Dutta RN; Sarkar DK
    J Indian Med Assoc; 2009 Apr; 107(4):219-22. PubMed ID: 19810365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combined use of topical benzoyl peroxide and tretinoin in the treatment of acne vulgaris.
    Handojo I
    Int J Dermatol; 1979; 18(6):489-96. PubMed ID: 158570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How patients experience and manage dryness and irritation from acne treatment.
    Feldman SR; Chen DM
    J Drugs Dermatol; 2011 Jun; 10(6):605-8. PubMed ID: 21637901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging topical antimicrobial options for mild-to-moderate acne: a review of the clinical evidence.
    Del Rosso J
    J Drugs Dermatol; 2008 Feb; 7(2 Suppl):s2-7. PubMed ID: 18404864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Trial of Silver Nanoparticle Gel and 1% Clindamycin Gel when Use in Combination with 2.5% Benzoyl Peroxide in Patients with Moderate Acne Vulgaris.
    Jurairattanaporn N; Chalermchai T; Ophaswongse S; Udompataikul M
    J Med Assoc Thai; 2017 Jan; 100(1):78-85. PubMed ID: 29911775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [1 percent clindamycin phosphate solution versus 5 percent benzoyl peroxide gel in papulopustular acne].
    Schmidt JB; Neumann R; Fanta D; Raab W
    Z Hautkr; 1988 May; 63(5):374-6. PubMed ID: 2970159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermatopharmacology of a new combination gel formulation for the topical treatment of acne.
    Levy S
    Cutis; 2001 Feb; 67(2 Suppl):8-12. PubMed ID: 11236214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adapalene 0.1%/benzoyl peroxide 2.5% gel: a review of its use in the treatment of acne vulgaris in patients aged ≥ 12 years.
    Keating GM
    Am J Clin Dermatol; 2011 Dec; 12(6):407-20. PubMed ID: 21967116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.